LLY

1,013.58

-0.49%↓

JNJ

229.36

-0.3%↓

ABBV

212.75

-0.41%↓

UNH

383.38

-1.52%↓

AZN

187.36

+1.46%↑

LLY

1,013.58

-0.49%↓

JNJ

229.36

-0.3%↓

ABBV

212.75

-0.41%↓

UNH

383.38

-1.52%↓

AZN

187.36

+1.46%↑

LLY

1,013.58

-0.49%↓

JNJ

229.36

-0.3%↓

ABBV

212.75

-0.41%↓

UNH

383.38

-1.52%↓

AZN

187.36

+1.46%↑

LLY

1,013.58

-0.49%↓

JNJ

229.36

-0.3%↓

ABBV

212.75

-0.41%↓

UNH

383.38

-1.52%↓

AZN

187.36

+1.46%↑

LLY

1,013.58

-0.49%↓

JNJ

229.36

-0.3%↓

ABBV

212.75

-0.41%↓

UNH

383.38

-1.52%↓

AZN

187.36

+1.46%↑

Home・Aktien・IQVIA Holdings Inc

IQVIA Holdings Inc

Geschlossen

BrancheGesundheitswesen

171.16 -1.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

165.13

Max

173.14

Schlüsselkennzahlen
By Trading Economics
Einkommen	-239M 275M
Verkäufe	-213M 4.2B
KGV Branchendurchschnitt	21.559 51.415
EPS	2.9
Gewinnspanne	6.625
Angestellte	93,000
EBITDA	-245M 802M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+24.67% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	21. Juli 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1.9B 29B
Vorheriger Eröffnungskurs	172.36
Vorheriger Schlusskurs	171.16

Nachrichtenstimmung

By Acuity

21%

79%

46 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

150.68 / 153.45 Unterstützung & Widerstand

IQVIA Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

IQVIA Holdings Inc Prognose

Kursziel

By TipRanks

24.67% Vorteil

12-Monats-Prognose

Durchschnitt 215.9 USD 24.67%

Hoch 245 USD

Tief 185 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für IQVIA Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

Buy

Halten

Sell

Basierend auf 12 Analysten, die in den letzten 3 Monaten Aktienbewertungen für IQVIA Holdings Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

150.68 / 153.45Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bearish.

Stimmung

By Acuity

46 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.